An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer

Study Overview
=================
Brief Summary
-----------------
This trial is to determine if prostate target delineation obtained through an ultrasound based system is equivalent in accuracy to the MRI image fusion, and if alignment correction vectors obtained from ultrasound imaging are of equivalent accuracy to orthogonal X-ray imaging for daily prostate positioning.

Detailed Description
-----------------
The investigators will also be assessing the following: Whether polymer-based markers can be adequately visualized on daily stereoscopic imaging compared to gold seed markers. Whether polymer-based markers are visible on ultrasound imaging. To determine if the polymer-based marker produces fewer artifacts on treatment planning CT scans than gold markers.

Official Title
-----------------
A Prospective Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer

Conditions
-----------------
Prostate Adenocarcinoma

Intervention / Treatment
-----------------
* Other: Polymer based fiducial placement


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Histologically confirmed prostate adenocarcinoma diagnosis of low risk or intermediate risk prostate cancer approved for proton therapy treatment at CDH ProCure Proton Therapy Center prescribed and consented for the placement of fiducial markers into the prostate as part of the standard treatment procedure capable of receiving an MRI of the pelvis region for prostate localization the prostate gland of eligible patients must be capable of imaging from an anterior trans-abdominal ultrasound as determined by the treating investigator must be fluent in the English language; must be able to provide written study consent Exclusion Criteria: Evidence of a large TURP defect per investigator discretion previous prostate cancer surgery including prostatectomy, hyperthermia and cryosurgery previous pelvic radiation for prostate cancer current grade 2 or above incontinence history of orthopedic procedures in the area of the treatment, specifically no prior hip replacement or procedure in which metallic or high density material remains which would be within stereoscopic kilovoltage imaging area prior permanent placement of any metallic or high density material within the prostate known allergy to ultrasonic gel
Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Males with prostate adenocarcinoma<br>English speaking males with histologically confirmed prostate adenocarcinoma and diagnosis of low risk or intermediate risk prostate cancer. | Other: Polymer based fiducial placement<br>* Fiducial marker placement with rectal ultrasound imaging.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Ultrasound versus MRI image fusion for daily prostate positioning | Determine if prostate target delineation obtained through an ultrasound based system is equivalent in accuracy to the MRI image fusion method, and if alighment crrection vectors obtained from ultransound imaging are of equivalent accuracy to orthogonal X-ray imaging for daily prostate positioning. | 4 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Polymer based marker visualization | To determine if polymer based markers can be adequately visualized on daily stereoscopic imaging compared to gold seed markers | 4 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Prostate cancer, Low risk, Intermediate risk, T1, T2a, T2b, Gleason 6, Gleason 7, PSA 10, PSA 20